Synlogic, Inc.
General ticker "SYBX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $14.9M (TTM average)
Synlogic, Inc. does not follow the US Stock Market performance with the rate: -14.1%.
Estimated limits based on current volatility of 5.2%: low 0.62$, high 0.69$
Factors to consider:
- Total employees count: 1 as of 2024
- Top business risk factors: Dependency on SYNB1934, Strategic risks and growth management, Potential dissolution or bankruptcy, Insufficient funding, History of losses
- Earnings for 15 months up through Q1 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.91$, 3.08$]
- 2025-12-31 to 2026-12-31 estimated range: [0.78$, 2.68$]
Financial Metrics affecting the SYBX estimates:
- Positive: with PPE of -0.6 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 148.93 > -0.60
- Positive: Shareholder equity ratio, % of 64.31 > 64.29
- Positive: Inventory ratio change, % of 0 <= 0
Short-term SYBX quotes
Long-term SYBX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $3.37MM | $0.01MM | $0.00MM |
| Operating Expenses | $58.53MM | $40.96MM | $4.01MM |
| Operating Income | $-55.16MM | $-40.95MM | $-4.01MM |
| Non-Operating Income | $-2.11MM | $17.60MM | $3.00MM |
| Interest Expense | $0.00MM | $0.00MM | $0.00MM |
| R&D Expense | $43.97MM | $9.15MM | $0.04MM |
| Income(Loss) | $-57.27MM | $-23.35MM | $-1.00MM |
| Taxes | $0.01MM | $0.01MM | $0.00MM |
| Net Income(Loss)* | $-57.28MM | $-23.36MM | $-1.00MM |
| Stockholders Equity | $42.66MM | $12.75MM | $11.86MM |
| Assets | $75.55MM | $19.83MM | $15.45MM |
| Operating Cash Flow | $-51.61MM | $-31.66MM | $-4.36MM |
| Capital expenditure | $0.21MM | $0.01MM | $0.00MM |
| Investing Cash Flow | $38.77MM | $25.34MM | $0.17MM |
| Financing Cash Flow | $20.94MM | $0.17MM | $0.00MM |
| Earnings Per Share** | $-8.81 | $-1.92 | $-0.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.